Page last updated: 2024-09-04

canertinib dihydrochloride and Nausea

canertinib dihydrochloride has been researched along with Nausea in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benson, L; Einzig, AI; Grove, WR; Lathia, CD; Roca, J; Sklarin, NT; Thomas, S; Wiernik, PH1

Trials

1 trial(s) available for canertinib dihydrochloride and Nausea

ArticleYear
A phase I trial and pharmacokinetic evaluation of CI-980 in patients with advanced solid tumors.
    Investigational new drugs, 1997, Volume: 15, Issue:3

    Topics: Adult; Aged; Antineoplastic Agents; Area Under Curve; Biological Availability; Carbamates; Central Nervous System Diseases; Drug Tolerance; Female; Humans; Male; Metabolic Clearance Rate; Middle Aged; Nausea; Neoplasms; Neutropenia; Pyrazines; Pyridines

1997